.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, West Coast Cure’s mix leaned on Vapor Pens at 42.38% share with a 0.23% year-over-year lift but a 1.28% month-over-month dip, while Flower held 22.93% share with a 17.05% YoY decline and a 2.69% MoM drop. Pre-Roll contributed 18.37% share with sales down 10.51% YoY and 0.59% MoM, contrasted by Concentrates at 15.22% share posting a 22.43% MoM jump despite a 2.71% YoY contraction. Edible remained a small 1.10% share with a 22.31% YoY decrease and a 1.07% MoM decline, and average price fell 4.02% YoY to $20.07. With Vapor Pens ranked 13th in California and overall brand sales down 7.10% YoY, the pattern implies dependence on a single lead category amid softening in Flower and Pre-Roll, while momentum in Concentrates is starting to rebalance mix risk.
The simultaneous 22.43% MoM surge in Concentrates against a 1.28% MoM dip in Vapor Pens and a 2.69% MoM decline in Flower implies a pivot toward value-seeking extract shoppers as price sensitivity rises alongside a 4.02% YoY average price decrease. With Vapor Pens still anchoring 42.38% share and a 13th-place rank in California, but Flower and Pre-Roll down 17.05% and 10.51% YoY respectively, the mix points to a need for margin defense through concentrates-led bundles and price-pack architecture rather than relying on volume from declining inhalable formats. The thesis is that West Coast Cure’s positioning should shift from a pen-and-flower center of gravity toward a dual-engine of Vapor Pens plus Concentrates to stabilize YoY contraction while protecting rank in Vapor Pens.
Competitive Landscape
West Coast Cure sits at rank #13 in CA Vapor Pens in May 2026, a 1-place improvement from #14 year over year but a 1-place decline from #12 in February 2026, while still well below its peak at #5 in May 2024; in contrast, STIIIZY held #1 with a -4.9% YoY sales change and Jetty Extracts climbed from #5 to #3 with a 40.6% YoY increase, indicating West Coast Cure’s modest rank lift is occurring as faster-rising rivals gain share. This combination of a minor YoY rank gain (+1) and recent quarter slippage (-1 vs three months ago), alongside competitors like Plug Play drifting from #3 to #4 with -14.2% YoY and Raw Garden steady at #2 with +14.7% YoY, implies West Coast Cure’s trajectory is stabilizing rather than accelerating, pointing to a need to re-catalyze momentum to reclaim territory between its current #13 and historical #5.
Notable Products
Garlic Juice (3.5g) posted the steepest decline in May 2026 at -33.5% MoM while sliding to rank 2, indicating Flower lost momentum even as CUREpen - Gas OG Distillate Oil Cartridge (1g) inched up 4.0% MoM to hold rank 1. Within Vapor Pens, CUREpen - Skywalker OG Distillate Cartridge (1g) fell -24.6% to rank 3 while CUREpen - Northern Lights Distillate Cartridge (1g) rose 13.9% to rank 5, and six of the top ten SKUs are Vapor Pens, concentrating share at the category’s premium formats. The mix suggests West Coast Cure is leaning into Vapor Pens as the volume anchor while tolerating volatility in single-strain Flower, implying portfolio emphasis is shifting toward cartridge depth over Flower breadth.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
